Skip to main content

Table 4 The clinical features of biopsied oral-facial malignancies in different countries in the Middle East

From: Oro-facial malignancy in north of Iraq: a retrospective study of biopsied cases

  Country Author(s) Year M:F Prevalence Age$ Most affected oral site
Oral malignancies Iraq Al–Niaimi [20] 2006 1.2:1 2% 58.3 Lip 41.1%, tongue 23.5%
Khudier [19] 2012 0.9:1 12.3%
Hassawi et al. [21] 2010 12.8%*
Mohammed [22] 2014 1.56:1 0.12% 39.1 Perioral 39.5%, buccal mucosa 18.6%
Museedi and Younis [16] 2014 1.37:1 2%  > 60 Tongue > lip
Aljazaeri et al. [23] 2020 1.38:1 19.1%  > 69 Tongue 46.7%
UAE Anis and Gaballah [8] 2013 14.9%
Yemen Halboub et al. [9] 2011 1:1 4% 58.4 Tongue 29.9%, floor 10.2%
Sudan Osman et al. [10] 2010 3:2 50%  > 50 Overlap 38.7%, tongue 9.2%
Saudi Arabia Ali et al. [12] 2013 1.42:1 9.9% 45.4  
Saleh et al. [11] 2017 0.6:1 38.8% 64.8 Tongue 43.7%, buccal mucosa 26.4%
AlHindi et al. [13] 2019 1.26:1 5.7% 49.52
Kuwait Ali and Sundaram [6] 2012 55.6%
Joseph et al. [7] 2019 1.4:1 3.6% 51.29
Jordan Telfah and Hammouri [14] 2014 1.6:1 1.5%
OSCC Iraq Al–Niaimi [20] 2006 1.2:1 80% Lip 51.5%,tongue 29.4%
Khudier [19] 2012 1.2:1 56.1% 50–70 Lip 50%, tongue20%
Hassawi et al. [21] 2010 3:1 58.9%
Mohammed [22] 2014 49%
Museedi and Younis [16] 2014 91%
Aljazaeri et al. [23] 2020 1.36:1 84.1%
UAE Anis and Gaballah [8] 2013 4.13:1 77% 54.9 Tongue 51.9%, buccal mucosa 19.48%
Yemen Halboub et al. [9] 2011 93.2%
Sudan Osman et al. [10] 2010 73.6%  > 50
Saudi Arabia Ali et al. [12] 2013 1.37:1 18.2% 60.39
Saleh et al. [11] 2017 0.54:1 93.1% 65.1 Tongue 43.7%, buccal mucosa 26.4%
AlHindi et al. [13] 2019 1.4:1 65.7% 56.6
Kuwait Ali and Sundaram [6] 2012 1:1 44.4% 53.9 Buccal mucosa 39%, tongue28.5%
Joseph et al. [7] 2019 64%
Jordan Telfah and Hammouri [14] 2014 67.3% Lip 23.7%, tongue 18.6%
  1. $Mean of age, – not mentioned